Expected Reactions

Part of Vaccines

Normal immune responses to vaccination — what to expect and how to distinguish them from adverse events.

Why This Matters

Fear of adverse reactions is one of the most common reasons people decline vaccination. In a community where medical knowledge is limited, even a normal vaccine reaction — a sore arm, mild fever, temporary fatigue — can cause alarm and spread distrust if it is unexpected and unexplained.

Practitioners have a responsibility to inform vaccine recipients what will happen. Normal reactions, explained in advance, build confidence. Unexpected reactions that were not disclosed undermine it. Beyond community trust, distinguishing expected normal reactions from true adverse events is essential clinical judgment. Missing an early sign of anaphylaxis because “all vaccine reactions look like this” is dangerous; panicking at a red sore arm that is entirely expected wastes resources and causes harm.

This article covers what is normal, what is borderline and worth monitoring, and what requires immediate intervention.

Local Reactions at the Injection Site

The most common vaccine reaction is local inflammation at the injection site. This is a direct immune response — the body recognizes something foreign and responds.

Expected local reactions:

• Redness (erythema) at injection site — typically 2-5 cm diameter, appearing within hours
• Swelling and induration (hardness) — may persist 1-3 days
• Tenderness and pain — worse with movement of the arm
• Warmth at site

Timing: Begin within hours, peak at 24-48 hours, resolve by 3-5 days.

What is normal vs. concerning:

Finding	Likely Normal	Investigate Further
Redness	< 10 cm	> 10 cm, spreading up arm
Swelling	Confined to injection site	Extends beyond site, firm and very hot
Pain	Sore to touch	Severe pain preventing arm use
Duration	Improving after day 3	Worsening after day 3

Manage local reactions:

• Clean wet cloth compress for 15-20 minutes
• Elevate arm if swollen
• Avoid rubbing or touching the site
• Do not apply hot poultice (increases inflammation)
• Willow bark tea or other anti-inflammatory plants if severe
• Normal activities can continue

Large local reactions (Arthus reactions): Some individuals develop exceptionally large local reactions (> 10 cm) to vaccines they have received before, particularly tetanus toxoid. This is an immune complex reaction in individuals with very high existing antibody levels — essentially, they are already over-immune and the dose is redundant. These reactions are alarming in appearance but rarely dangerous. Apply cold compress; monitor for systemic involvement.

Systemic Reactions

Fever: Mild to moderate fever (37.5-39°C) within 24-48 hours of vaccination is expected, particularly with inactivated bacterial vaccines and live attenuated vaccines. Fever reflects systemic immune activation — the body’s response to recognized foreign material.

Duration: typically 1-2 days. Fever resolving by day 3 is normal. Fever persisting beyond 5 days or spiking above 40°C warrants evaluation for concurrent infection or unusual vaccine reaction.

Management: maintain hydration, use tepid compresses. Willow bark or meadowsweet for anti-fever properties if available and temperature is very uncomfortable. Do not over-suppress mild fever — it is part of the immune response.

Malaise and fatigue: General feeling of illness for 1-3 days. Expected. The immune system is doing significant work.

Headache: Common, especially with live attenuated vaccines. Treat with rest and hydration.

Myalgias (muscle aches): Generalized body aches for 1-2 days. Expected.

Lymph node swelling: Regional lymph node enlargement (e.g., axillary nodes after arm injection) within 1-2 weeks. Represents local immune cell proliferation. Expected. Typically resolves within 2-4 weeks.

Vaccine-Specific Expected Reactions

Different vaccines produce characteristic reactions:

Cowpox/Vaccinia (smallpox): A predictable sequence of local lesion development is the expected reaction and the sign of successful take:

• Day 3-4: red papule (bump) at scarification site
• Day 5-6: vesicle (fluid-filled blister)
• Day 8-9: pustule (pus-filled); maximum size, mild fever, swollen axillary nodes
• Day 10-14: crust formation
• Day 14-21: crust separates, leaving characteristic scar

No local reaction after vaccinia inoculation — no “take” — indicates either failure of administration technique, inadequate vaccine potency, or pre-existing immunity. Re-vaccinate with fresh material.

BCG (tuberculosis): Similar to vaccinia but smaller scale:

• Week 2-4: small papule at injection site
• Week 4-6: pustule or ulcer (0.5-1 cm)
• Month 2-3: heals with characteristic scar (4-8 mm)

Oral live vaccines: Mild gastrointestinal upset (nausea, loose stool) for 1-2 days. Expected.

Injected live viral vaccines (measles, rubella): Mild measles-like or rubella-like illness 7-12 days after vaccination. Fever, mild rash, occasional coryza (runny nose). Expected and represents vaccine virus replication. Much milder than natural disease.

True Adverse Events

These require intervention and reporting:

Anaphylaxis:

• Timing: within 15-30 minutes of vaccination
• Signs: hives, throat tightness, difficulty breathing, rapid pulse, blood pressure drop, loss of consciousness
• Action: immediate treatment (epinephrine if available, airway management, lay flat with legs elevated)
• This is a medical emergency

Febrile seizures:

• Seen occasionally in young children with high fever (not vaccine-specific — any fever can cause seizures in susceptible children aged 6 months - 5 years)
• If brief (< 5 minutes) and child recovers fully: treat fever, monitor, does not require withholding future vaccines
• If prolonged (> 5 minutes): medical emergency; seek advanced care

Progressive vaccinia:

• In severely immunocompromised individuals, vaccinia (smallpox vaccine) can spread uncontrollably
• Lesion does not heal and progresses beyond the site; satellite lesions appear
• This is a serious adverse event — requires isolation of patient and discontinuation of vaccinia use in that individual

Vaccine-associated paralytic polio (VAPP):

• Extremely rare — occurs approximately 1 per 750,000 first doses of oral polio vaccine
• Vaccinated person or close contact develops paralysis
• Historical rate in mass campaigns: accepted as far lower than disease burden from wild polio

Communicating Expected Reactions to Recipients

Before vaccination, tell each recipient:

1. “Your arm will be sore and may be red and swollen for 2-3 days at the injection site. This is normal.”

2. “You may feel tired or have mild fever and body aches for 1-2 days after. This is your body building protection.”

3. “If you develop any of the following within 30 minutes, return immediately: difficulty breathing, throat tightness, severe hives, dizziness.”

4. “If you develop high fever (burning hot to touch) lasting more than 3 days after vaccination, or any unusual symptoms, come back for assessment.”

5. “These reactions are signs the vaccine is working. They are much less severe than the disease itself.”

Ask recipients to wait 15-30 minutes after injection before leaving the vaccination site. Anaphylaxis typically occurs in this window and is manageable if observed. A vaccine recipient who has collapsed 20 minutes after leaving a distant vaccination post is far harder to save than one who collapsed in your presence.

Documentation of Reactions

Record every reaction, expected and unexpected:

• Recipient identifier
• Vaccine type and lot
• Date
• Reaction type and severity (mild/moderate/severe)
• Treatment given
• Outcome

This data accumulates into safety surveillance — the means by which rare adverse events are identified. A single practitioner reporting a single unusual reaction means little. Fifty practitioners across a region reporting the same unusual reaction after the same vaccine lot means a lot defect.

The paperwork feels tedious but is how safe vaccine programs maintain their safety.